121.79
Irhythm Holdings Inc stock is traded at $121.79, with a volume of 636.76K.
It is up +2.61% in the last 24 hours and down -10.38% over the past month.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$118.69
Open:
$120
24h Volume:
636.76K
Relative Volume:
0.96
Market Cap:
$3.94B
Revenue:
$747.14M
Net Income/Loss:
$-44.55M
P/E Ratio:
-86.33
EPS:
-1.4108
Net Cash Flow:
$34.52M
1W Performance:
+3.80%
1M Performance:
-10.38%
6M Performance:
-28.94%
1Y Performance:
+14.25%
Irhythm Holdings Inc Stock (IRTC) Company Profile
Name
Irhythm Holdings Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
IRTC
Irhythm Holdings Inc
|
121.79 | 3.84B | 747.14M | -44.55M | 34.52M | -1.4108 |
|
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-05-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Holdings Inc Stock (IRTC) Latest News
iRhythm Holdings, Inc. (IRTC) reports $5.6M net income, 70.9% gross margin in Q4 2025 - MSN
[SCHEDULE 13G] iRhythm H... - Stock Titan
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - MSN
IRTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund - The Globe and Mail
This leading manufacturer of specialized heart monitors has recently attracted the attention of a prominent healthcare investment fund. - Bitget
iRhythm (IRTC) director granted 2,218 RSUs vesting from 2027 - Stock Titan
Director Jason H. Patten reports initial holdings in iRhythm Holdings (IRTC) - Stock Titan
How Investors Are Reacting To iRhythm Holdings (IRTC) Adding UnitedHealth Strategy Executive To Its Board - Sahm
iRhythm Holdings, Inc. (IRTC) Q4 earnings and revenues beat estimates - MSN
Insider Sell: Mervin Smith Sells Shares of iRhythm Holdings Inc (IRTC) - GuruFocus
iRhythm (NASDAQ: IRTC) EVP sells 2,585 shares under 10b5-1 plan - Stock Titan
Holocene Advisors LP Buys 160,186 Shares of iRhythm Technologies $IRTC - MarketBeat
iRhythm appoints UnitedHealth executive to board - Investing.com Nigeria
Proposed sale of 2,585 performance shares by Mervin Smith (IRTC) - Stock Titan
Cinctive Capital Management LP Takes $4.82 Million Position in iRhythm Technologies $IRTC - MarketBeat
Algert Global LLC Increases Stake in iRhythm Technologies $IRTC - MarketBeat
A Look At iRhythm Holdings (IRTC) Valuation After Recent Share Price Weakness - simplywall.st
Final Deadline Approaching on April 2, 2021: Kessler Topaz Meltzer & Check, LLP Reminds iRhythm Technologies, Inc. Investors of Class Action Lawsuit Deadline - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is It Time To Revisit iRhythm Holdings (IRTC) After The Recent Share Price Slide? - simplywall.st
iRhythm appoints UnitedHealth executive to board By Investing.com - Investing.com Australia
Irhythm Technologies appoints Jason Patten to board - The Globe and Mail
Latest IRTC NewsiRhythm Technologies to Report Second Quart... - Stock Titan
Schroder Investment Management Group Has $27.81 Million Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm Holdings Appoints Jason Patten to Board of Directors – March 2026 Announcement 6 - Minichart
iRhythm Holdings Appoints Jason Patten to its Board of Directors - Sahm
Jason Patten joins iRhythm (NASDAQ: IRTC) board and audit committee - Stock Titan
Victory Capital Management Inc. Acquires 18,053 Shares of iRhythm Technologies $IRTC - MarketBeat
Mackenzie Financial Corp Sells 274,552 Shares of iRhythm Technologies $IRTC - MarketBeat
iRhythm Holdings (IRTC) Sees Price Target Lowered by Citigroup | - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $214.00 by Analysts at Citigroup - MarketBeat
iRhythm Technologies $IRTC Shares Sold by Capital Research Global Investors - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2025 earnings call transcript - MSN
Quantbot Technologies LP Trims Stock Holdings in iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Short Interest Up 20.1% in February - MarketBeat
iRhythm Technologies $IRTC Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Insider Selling: iRhythm Technologies (NASDAQ:IRTC) CAO Sells 816 Shares of Stock - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) EVP Minang Turakhia Sells 4,027 Shares - MarketBeat
iRhythm Holdings (NASDAQ: IRTC) EVP sells 2,830 RSU tax shares - Stock Titan
iRhythm (IRTC) officer sells 4,027 shares to cover RSU taxes - Stock Titan
iRhythm Holdings (IRTC) EVP sells 1,352 shares for RSU tax withholding - Stock Titan
iRhythm (IRTC) officer sells 4,444 shares to cover RSU tax obligations - Stock Titan
iRhythm (IRTC) CBO/CLO sells 4,357 shares to cover RSU taxes - Stock Titan
Irhythm Holdings Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):